‘Hopeful technology’ could change detection, diagnosis of deadly ovarian cancer
Ovarian cancer claims the lives of more than 14,000 women in the U.S. each year, ranking fifth among cancer deaths in women. A multidisciplinary team at Washington University has found an innovative way to use sound and light to diagnose ovarian tumors, which may lead to a promising new diagnostic imaging technique to improve current standard of care.
CT screening reduces lung-cancer deaths in heavy smokers
In a study of heavy smokers, fewer screened with low-dose CT scans died, compared with similar smokers screened with standard chest X-rays. The National Cancer Institute ran the 33-center National Lung Screening Trial to learn whether more sensitive screening could have an impact on lung-cancer deaths, and Washington University researchers involved in the study say it did.
Detection of breast cancer recurrence possible with simple blood test
Detecting breast cancer recurrence with a simple blood testPhysicians treating women with breast cancer recognize the need for a specific and sensitive method to monitor disease recurrence, so they should be encouraged by a new study that describes a biomarker that seems to fill those criteria. Researchers at the School of Medicine have shown that mammaglobin, a protein secreted by breast tumor cells, can readily be detected in the blood serum of patients with metastatic breast cancer using an inexpensive, reliable clinical test.
Detection of breast cancer recurrence possible with simple blood test
Detecting breast cancer recurrence with a simple blood test.Physicians treating women with breast cancer recognize the need for a specific and sensitive method to monitor disease recurrence, so they should be encouraged by a new study that describes a biomarker that seems to fill those criteria. Researchers at Washington University School of Medicine in St. Louis have shown that mammaglobin, a protein secreted by breast tumor cells, can readily be detected in the blood serum of patients with metastatic breast cancer using an inexpensive, reliable clinical test.